EXLA Resources Inc. (EXLA)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2021 | 2020 | 2019 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 77.4 Thousand | 6950.00 | 10.5 Thousand | 41.31 Thousand | 21.67 Thousand | 29.48 Thousand |
| Selling, General and Administrative Expenses | 77.4 Thousand | 6950.00 | 10.5 Thousand | 41.31 Thousand | 21.67 Thousand | 29.48 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 77.4 Thousand | 6950.00 | 10.5 Thousand | 41.31 Thousand | 21.67 Thousand | 29.48 Thousand |
| Operating Income | -77.4 Thousand | -6950.00 | -10.5 Thousand | -41.31 Thousand | -21.67 Thousand | -29.48 Thousand |
| Interest Expense | 190.00 | 132.00 | 60.00 | - | - | - |
| Income Tax Expense | -236.55 Thousand | -206.29 Thousand | -171.86 Thousand | - | - | - |
| Earnings before Tax | -77.59 Thousand | -7082.00 | -10.56 Thousand | -41.31 Thousand | -21.67 Thousand | -29.48 Thousand |
| Net Income | -77.59 Thousand | -7082.00 | -10.56 Thousand | -41.31 Thousand | -21.67 Thousand | -29.48 Thousand |
| Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 456 Million | 126 Million | 126 Million | 261.46 Million | 261.46 Million | 261.46 Million |
| Weighted Average Shares Outstanding (Diluted) | 456 Million | 126 Million | 126 Million | 261.46 Million | 261.46 Million | 261.46 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -77.4 Thousand | -6950.00 | -10.5 Thousand | -41.31 Thousand | -21.67 Thousand | -29.48 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | 8639.00 | 31.05 Thousand |
| Selling, General and Administrative Expenses | - | - | - | - | 8639.00 | 31.05 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | - | - | - | - | 8639.00 | 31.05 Thousand |
| Operating Income | - | - | - | - | -8640.00 | -31.05 Thousand |
| Interest Expense | - | - | - | - | 530.00 | 170.00 |
| Income Tax Expense | - | - | - | - | -27.08 Thousand | -86.06 Thousand |
| Earnings before Tax | - | - | - | - | -9170.00 | -31.22 Thousand |
| Net Income | - | - | - | - | -9170.00 | -31.22 Thousand |
| Earnings Per Share Basic | - | - | - | - | - | - |
| Earnings Per Share Diluted | - | - | - | - | - | - |
| Weighted Average Shares Outstanding | - | - | - | - | 738 Million | 738 Million |
| Weighted Average Shares Outstanding (Diluted) | - | - | - | - | 738 Million | 738 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | - | - | - | - | -8640.00 | -31.05 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
MAB1
HOFI
NZERF
KPL
VISI
HGH